InfuSystem to Report Second Quarter 2022 Financial Results on August 4, 2022

Investor Conference Call to be held 9:00 a.m. Eastern Time ROCHESTER HILLS, Mich.–(BUSINESS WIRE)–InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today it will issue second quarter 2022 financial results on Thursday, August … [Read more…]

SOL Global Provides Interim Unaudited Financials for the Second Quarter Ended May 2022

TORONTO–(BUSINESS WIRE)–SOL Global Investments Corp. (“SOL Global” or the “Company”) (CSE: SOL) (OTCPK: SOLCF) (Frankfurt: 9SB) is pleased to provide its investors with unaudited financials for the second quarter ended May 31, 2022, and a general operational update concerning the Company’s assets and investments. All figures in this press release are in Canadian dollars, unless … [Read more…]

Final Deadline Approaching for Claim in Dow Corning Breast Implant Bankruptcy, Announces Claimants’ Advisory Committee

APPROVED CLAIMANTS MUST PROVIDE CURRENT ADDRESS TO RECEIVE PAYMENT DOW CORNING BREAST IMPLANT SETTLEMENT SEEKS TO DISTRIBUTE MILLIONS OF DOLLARS IN UNPAID AWARDS TO 13,000 WOMEN HOUSTON–(BUSINESS WIRE)–#BREASTIMPLANTMONEY–Women who had Dow Corning breast implants (and their heirs if the claimant is deceased) and who were approved for either a Rupture and/or Disease claim are eligible … [Read more…]

Rhino Health USA, Inc. Closes $58 million New Markets Tax Credit Financing

Company will use the money to build its Fort Worth manufacturing expansion FORT WORTH, Texas–(BUSINESS WIRE)–Fort Worth-based Rhino Health USA, Inc. today announced the closing of a $58 million New Markets Tax Credit (NMTC) transaction that will help fund the company’s $200 million investment for its large-scale manufacturing expansion in North Texas. “We are pleased … [Read more…]

Donaldson Company Declares Quarterly Cash Dividend

MINNEAPOLIS–(BUSINESS WIRE)–Donaldson Company, Inc. (NYSE: DCI) today announced that its Board of Directors declared a regular cash dividend of 23.0 cents per share. The dividend is payable August 31, 2022, to shareholders of record on August 16, 2022. Donaldson is a member of the S&P High-Yield Dividend Aristocrats Index and calendar year 2021 marked the … [Read more…]

Dr. Reddy’s Laboratories enters into a licensing agreement with Slayback Pharma to obtain exclusive rights in the first-to-file ANDA for the private label version of Lumify® in the U.S.

HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–$RDY #Alcon–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced that it has entered into a licensing agreement with Princeton, New Jersey based Slayback Pharma LLC (“Slayback”), to acquire rights in Slayback’s Brimonidine Tartrate Ophthalmic … [Read more…]

2022 Directory of Pharmaceutical Venture Capital & Private Equity Firms – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–“The Directory of Pharmaceutical Venture Capital & Private Equity Firms 2022” directory has been added to ResearchAndMarkets.com’s offering. This useful resource brings together both venture capital and private equity investors involved in pharmaceuticals, biotechnology and medical devices. This edition has been extensively updated, offering valuable, current, and detailed information to individuals, entrepreneurs, and businesses … [Read more…]

Precious Metals E-Waste Recovery Global Market Report 2022 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Precious Metals E-Waste Recovery Global Market Report 2022 “ report has been added to ResearchAndMarkets.com’s offering. The global precious metals e-waste recovery market is expected to grow from $9.22 billion in 2021 to $9.61 billion in 2022 at a compound annual growth rate (CAGR) of 4.28%. The market is expected to reach $11.51 … [Read more…]

Global Anemia And Other Blood Disorder Drugs Markets, 2016-2021, 2021-2026F, 2031F by Type, Distribution Channel, Route of Administration, Anemia Type – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Anemia And Other Blood Disorder Drugs Global Market Report 2022, Type, Distribution Channel, Route of Administration, Anemia Type” report has been added to ResearchAndMarkets.com’s offering. The global anemia and other blood disorder drugs market is expected to grow from $10.29 billion in 2021 to $11.10 billion in 2022 at a compound annual growth … [Read more…]